Articles Referencing ACT
FDA Accepts Actavis NDA - Analyst Blog
5/20/2013, 12:05 pm from Zacks.com in Investing, Business, Stocks
The US Food and Drug Administration (FDA) recently accepted
Actavis, Inc.'s ( ACT ) new drug
application for its oral contraceptive candidate. The company is
looking to get its... Read >>
Pre-Market Most Active for May 20, 2013 : WCRX, RDS/B, YHOO, ACT, BAC, BP, AU, NBG, GILD, ASML, WBSN, ZNGA
5/20/2013, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is to 3,026.98. The total Pre-Market
volume is currently 9,282,494 shares traded.
The following are the
most active stocks for the pre-market session :... Read >>
Earnings Beat at Warner Chilcott - Analyst Blog
5/13/2013, 10:48 am from Zacks.com in Investing, Business, Earnings, Stocks
Warner Chilcott' s ( WCRX ) first quarter
2013 earnings (excluding special items) of 92 cents per share
handsomely beat the Zacks Consensus Estimate of 85 cents. Lower
selling, general... Read >>
Earnings Beat at Endo Health, Sales Slip - Analyst Blog
5/8/2013, 6:24 pm from Zacks.com in Investing, Business, Earnings, Stocks
Endo Health Solutions' ( ENDP ) first quarter
2013 earnings (excluding special items) of $1.09 per share beat the
Zacks Consensus Estimate by a penny and increased 25% from the
year-ago... Read >>
Earnings Miss at Perrigo - Analyst Blog
5/7/2013, 12:24 pm from Zacks.com in Investing, Business, Earnings, Stocks
Perrigo Company 's ( PRGO ) third quarter
fiscal 2013 (ended Mar 30, 2013) earnings of $1.42 per share fell
short of the Zacks Consensus Estimate by 2 cents.
Lower-than-expected revenues... Read >>
Acorda Incurs Loss, Maintains Guidance - Analyst Blog
5/6/2013, 3:25 pm from Zacks.com in Investing, Business, Stocks
Acorda Therapeutics Inc. 's ( ACOR ) first quarter
2013 loss (including share-based compensation charges but excluding
other special items) of 3 cents per share compared unfavorably... Read >>
Perrigo Likely to Report In Line Earnings - Analyst Blog
5/6/2013, 3:23 pm from Zacks.com in Investing, Business, Earnings, Stocks
We expect Perrigo Company ( PRGO ) to report in
line third quarter fiscal 2013 results before the opening bell on
May 7. The company's fiscal year ends on the last Saturday of Jun
every... Read >>
Company News for May 3, 2013 - Corporate Summary
5/3/2013, 9:29 am from Zacks.com in Investing, Business, Investing Ideas, Stocks
• Actavis Inc (NYSE: ACT ) reported first
quarter earnings per share of $1.99, beating the Zacks Consensus
Estimate of $1.87
• BEAM Inc (NYSE: BEAM ) posted first
quarter earnings per... Read >>
Actavis Beats on Earnings, Raises View - Analyst Blog
5/2/2013, 9:55 am from Zacks.com in Investing, Business, Earnings, Stocks
Actavis, Inc.'s ( ACT ) first quarter
2013 earnings of $1.99 per share beat the Zacks Consensus Estimate
of $1.87 and increased 21% from the year-ago earnings. Revenues for the reported... Read >>
Shire Settles Lawsuit with Actavis - Analyst Blog
5/1/2013, 1:48 pm from Zacks.com in Investing, Business, Stocks
Shire ( SHPG ) recently
announced that the company settled its pending litigation with
Actavis, Inc ( ACT ), formerly known
as Watson Pharmaceuticals. The litigation was primarily... Read >>
Pre-Market Primer: Consumer Spending and Income Mark Tepid Rise
4/29/2013, 8:47 am from Minyanville in Investing, Earnings
Gold and stocks rallied this morning as the dollar weakened and
consumer spending figures came in slightly better than
expected.
Consumer spending, the heartbeat of the American economy, grew... Read >>
Orphan Drug Status for Teva/Xenon Drug - Analyst Blog
4/26/2013, 4:22 pm from Zacks.com in Investing, Business, Stocks
The US Food and Drug Administration (FDA) recently granted
orphan drug designation to Teva Pharmaceutical Industries
Ltd ( TEVA
) and Xenon Pharmaceuticals Inc. for their pain... Read >>
Favorable Court Ruling for Actavis - Analyst Blog
4/19/2013, 6:13 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) recently
re-launched Vestura (3 mg drospirenone and 0.02 mg ethinyl
estradiol), the company's generic version of
Bayer's ( BAYRY ) oral
contraceptive, Yaz. Actavis... Read >>
Actavis Settles with Valeant - Analyst Blog
4/11/2013, 1:09 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ), and
Valeant Pharmaceuticals International, Inc.'s ( VRX ) Medicis
Pharmaceutical Corporation recently entered into settlement
agreements regarding a couple... Read >>
TRO on Actavis Sale of Generic Pulmicort Respules - Analyst Blog
4/10/2013, 10:50 am from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) recently said
that the US District Court for the District of New Jersey has
granted AstraZeneca 's ( AZN ) motion to issue a
temporary restraining order (TRO)... Read >>